Folinic Acid in Autism

Last updated: November 12, 2019
Sponsor: University of California, San Francisco
Overall Status: Completed

Phase

2/3

Condition

Asperger's Disorder

Williams Syndrome

Autism

Treatment

N/A

Clinical Study ID

NCT03771560
Folinic acid
  • Ages 5-25
  • All Genders

Study Summary

An examination of changes in urinary metabolites with use of folinic acid in children with autism spectrum disorder (ASD). Investigators will also measure behavioral measures and academic measures monthly at school with teachers and parents report.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Between ages 5 and 25

Exclusion

Exclusion Criteria:

  • Not currently taking folinic acid

Study Design

Total Participants: 18
Study Start date:
February 15, 2018
Estimated Completion Date:
June 30, 2018

Study Description

Children enrolled in Oak Hill School will enroll in this study and take folinic acid supplement twice a day for 12 weeks period. Behavioral measures and urinary metabolites will be collected pre and post treatment. Behavioral measures will be taken again at 16 weeks, after 4 weeks of not dosing.

Connect with a study center

  • University of California, San Francisco

    San Francisco, California 94143
    United States

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.